The Warburg effect and its cancer therapeutic implications

  • Zhao Chen
  • Weiqin Lu
  • Celia Garcia-Prieto
  • Peng Huang
MIni Review

DOI: 10.1007/s10863-007-9086-x

Cite this article as:
Chen, Z., Lu, W., Garcia-Prieto, C. et al. J Bioenerg Biomembr (2007) 39: 267. doi:10.1007/s10863-007-9086-x

Abstract

Increased aerobic glycolysis in cancer, a phenomenon known as the Warburg effect, has been observed in various tumor cells and represents a major biochemical alteration associated with malignant transformation. Although the exact molecular mechanisms underlying this metabolic change remain to be elucidated, the profound biochemical alteration in cancer cell energy metabolism provides exciting opportunities for the development of therapeutic strategies to preferentially kill cancer cells by targeting the glycolytic pathway. Several small molecules capable of inhibiting glycolysis in experimental systems have been shown to have promising anticancer activity in vitro and in vivo. This review article provides a brief summary of our current understanding of the Warburg effect, the underlying mechanisms, and its influence on the development of therapeutic strategies for cancer treatment.

Keywords

Warburg effect Glycolysis Inhibitor Mitochondria Cancer therapeutics Drug resistance Reactive oxygen species (ROS) Oncogene Hypoxia 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Zhao Chen
    • 1
  • Weiqin Lu
    • 1
  • Celia Garcia-Prieto
    • 1
  • Peng Huang
    • 1
  1. 1.Department of Molecular PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations